Sumitomo Mitsui Trust Group, Inc.
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in RXRX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$20,227,891
+$3,590,883 QoQ
Shares Held
5,511,687
+1.7% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 344 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sumitomo Mitsui Trust Group, Inc. holds $1,410,786,189 across 37 Biotechnology names. RXRX ranks #14 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
611,907 | $303,952,564 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
282,199 | $175,962,364 | |
| 3 | TECH |
BIO-TECHNE Corp
|
2,067,324 | $146,056,440 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
3,455,043 | $118,577,075 | |
| 5 | TWST |
Twist Bioscience Corp
|
1,000,344 | $102,915,390 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
325,379 | $97,948,840 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
1,720,734 | $93,848,832 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,187,943 | $66,607,964 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,227,891 | 5,511,687 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $16,637,008 | 5,419,221 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $25,443,992 | 6,221,025 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $36,433,387 | 7,465,858 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $41,328,789 | 8,167,745 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $44,855,412 | 8,479,284 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $60,708,862 | 8,980,601 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $64,362,737 | 9,766,728 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $74,902,725 | 9,987,030 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $103,317,145 | 10,362,803 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $90,749,270 | 9,203,780 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $26,951,898 | 3,523,124 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $6,255,378 | 837,400 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $3,348,186 | 501,977 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $3,504,364 | 454,522 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $5,221,473 | 490,740 | Shares | Defined | 2022-10-21 | |
| 2022-06-30 | $3,255,194 | 399,901 | Shares | Defined | 2022-07-26 | |
| 2021-12-31 | $6,320,867 | 368,994 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $9,415,553 | 409,194 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $7,796,692 | 213,608 | Shares | Defined | 2021-08-02 | |
| No filing history on record for this holder in this stock. | ||||||